Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - NYSE:EXK - CA29258Y1034 - Common Stock

8.14 USD
+0.94 (+13.06%)
Last: 11/10/2025, 10:11:08 AM
Fundamental Rating

3

Taking everything into account, EXK scores 3 out of 10 in our fundamental rating. EXK was compared to 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of EXK have multiple concerns. EXK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
EXK had positive earnings in 4 of the past 5 years.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of EXK (-6.99%) is worse than 64.29% of its industry peers.
EXK has a worse Return On Equity (-13.16%) than 65.58% of its industry peers.
EXK's Return On Invested Capital of 0.28% is in line compared to the rest of the industry. EXK outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXK is significantly below the industry average of 12.57%.
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROIC 0.28%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK has a Operating Margin (1.11%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXK has declined.
EXK has a Gross Margin (16.47%) which is in line with its industry peers.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 1.11%
PM (TTM) N/A
GM 16.47%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
The number of shares outstanding for EXK has been increased compared to 5 years ago.
Compared to 1 year ago, EXK has a worse debt to assets ratio.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXK has an Altman-Z score of 2.33. This is not the best score and indicates that EXK is in the grey zone with still only limited risk for bankruptcy at the moment.
EXK has a Altman-Z score of 2.33. This is comparable to the rest of the industry: EXK outperforms 40.91% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
EXK has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.33
ROIC/WACC0.03
WACC8.15%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.93 indicates that EXK may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, EXK is doing worse than 85.71% of the companies in the same industry.
EXK has a Quick Ratio of 0.93. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.65, EXK is doing worse than 82.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.65
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.
EXK shows a small growth in Revenue. In the last year, the Revenue has grown by 5.93%.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%108.45%

3.2 Future

Based on estimates for the next years, EXK will show a very strong growth in Earnings Per Share. The EPS will grow by 53.69% on average per year.
The Revenue is expected to grow by 38.81% on average over the next years. This is a very strong growth
EPS Next Y150.5%
EPS Next 2Y219.08%
EPS Next 3Y135.04%
EPS Next 5Y53.69%
Revenue Next Year96.05%
Revenue Next 2Y87.63%
Revenue Next 3Y58.97%
Revenue Next 5Y38.81%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 12.44, which indicates a correct valuation of EXK.
EXK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXK is cheaper than 75.97% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.73. EXK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 12.44
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

EXK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.2
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXK's earnings are expected to grow with 135.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y219.08%
EPS Next 3Y135.04%

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (11/10/2025, 10:11:08 AM)

8.14

+0.94 (+13.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners50.49%
Inst Owner Change6.13%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap2.36B
Revenue(TTM)217.64M
Net Income(TTM)-69.64M
Analysts78.33
Price Target9.67 (18.8%)
Short Float %7.05%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2921.78%
Min EPS beat(2)-5248.51%
Max EPS beat(2)-595.05%
EPS beat(4)1
Avg EPS beat(4)-1901.52%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1033.96%
EPS beat(12)2
Avg EPS beat(12)-718.86%
EPS beat(16)3
Avg EPS beat(16)-586.26%
Revenue beat(2)2
Avg Revenue beat(2)0.08%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)6
Avg Revenue beat(8)-0.8%
Revenue beat(12)8
Avg Revenue beat(12)-0.12%
Revenue beat(16)9
Avg Revenue beat(16)-2.55%
PT rev (1m)24.22%
PT rev (3m)36.84%
EPS NQ rev (1m)47.37%
EPS NQ rev (3m)75%
EPS NY rev (1m)14.29%
EPS NY rev (3m)-79.17%
Revenue NQ rev (1m)-2.82%
Revenue NQ rev (3m)18.71%
Revenue NY rev (1m)4.71%
Revenue NY rev (3m)12.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.44
P/S 9.53
P/FCF N/A
P/OCF 87.19
P/B 4.46
P/tB 4.46
EV/EBITDA 54.2
EPS(TTM)-0.15
EYN/A
EPS(NY)0.65
Fwd EY8.04%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.09
OCFY1.15%
SpS0.85
BVpS1.82
TBVpS1.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROCE 0.35%
ROIC 0.28%
ROICexc 0.3%
ROICexgc 0.3%
OM 1.11%
PM (TTM) N/A
GM 16.47%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 503.82%
Cap/Sales 76.86%
Interest Coverage 0.27
Cash Conversion 66.81%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.65
Altman-Z 2.33
F-Score3
WACC8.15%
ROIC/WACC0.03
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y150.5%
EPS Next 2Y219.08%
EPS Next 3Y135.04%
EPS Next 5Y53.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%108.45%
Revenue Next Year96.05%
Revenue Next 2Y87.63%
Revenue Next 3Y58.97%
Revenue Next 5Y38.81%
EBIT growth 1Y100.07%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year219.22%
EBIT Next 3Y109.71%
EBIT Next 5Y52.95%
FCF growth 1Y-134.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.85%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 4 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Fairly Valued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 150.5% in the next year.